Showing results (31-40 of 47) with videos related to
Sort By:
Pageof 5
Bioscience Trends|March 17, 2020
Novel conjugates of endoperoxide and 4-anilinoquinazoline induce myeloma cell apoptosis by inhibiting the IGF1-R/AKT/mTOR signaling pathwayYujia Xu, Kun Zeng, Xiaoge Wang, et al.Journal of Hematology & Oncology|July 5, 2017
The ubiquitin-conjugating enzyme UBE2O modulates c-Maf stability and induces myeloma cell apoptosisYujia Xu, Zubin Zhang, Jie Li, et al.The Journal of Biological Chemistry|April 7, 2023
The ubiquitin ligase HERC4 suppresses MafA transcriptional activity triggered by GSK3β in myeloma by atypical K63-linked polyubiquitinationZubin Zhang, Mei Li, Peng Lin, et al.The Journal of Biological Chemistry|December 12, 2019
The deubiquitinase USP7 stabilizes Maf proteins to promote myeloma cell survivalYuanming He, Siyu Wang, Jiefei Tong, et al.The Journal of Biological Chemistry|August 4, 2022
Induction of zinc finger protein RNF6 auto-ubiquitination for the treatment of myeloma and chronic myeloid leukemiaHaixia Zhuang, Ying Ren, Chenyu Mao, et al.Oncotarget|December 5, 2014
A novel PI3K inhibitor PIK-C98 displays potent preclinical activity against multiple myelomaJingyu Zhu, Man Wang, Yang Yu, et al.Blood|August 26, 2020
Targeting the Otub1/c-Maf axis for the treatment of multiple myelomaYujia Xu, Min Xu, Jiefei Tong, et al.Molecular Pharmacology|January 12, 2011
The tricyclic antidepressant amitriptyline inhibits D-cyclin transactivation and induces myeloma cell apoptosis by inhibiting histone deacetylases: in vitro and in silico evidenceXinliang Mao, Tingjun Hou, Biyin Cao, et al.Oncotarget|December 21, 2019
Correction: A novel PI3K inhibitor PIK-C98 displays potent preclinical activity against multiple myelomaJingyu Zhu, Man Wang, Yang Yu, et al.Proteomics|November 24, 2016
Protein-phosphotyrosine proteome profiling by superbinder-SH2 domain affinity purification mass spectrometry, sSH2-AP-MSJiefei Tong, Biyin Cao, Gregory D Martyn, et al.Pageof 5